Gate Bioscience
Gate Bioscience is a biotechnology company that specializes in a small molecule modality to treat biology’s intractable diseases. The company pioneers a novel therapeutic modality called Molecular Gates, small-molecule drugs that selectively block and eliminate disease-causing proteins before they are secreted. Their discovery platform combines a library of privileged gate molecules, specialized assays focused on protein secretion, and deep biological insights into the secretory translocon (Sec61) pathway. By binding to the secretory channel of specific target proteins, molecular gates prevent their export and cause their intracellular degradation, which could provide oral, highly selective therapies.
Domain
gatebio.com
Country
United StatesIndustry
BiotechnologyEmployees
11-50
Last Funding
$65.0M
Founded
2020
Tech Stack (11 technologies)
Frequently Asked Questions
What technologies does Gate Bioscience use?+
Gate Bioscience uses 11 technologies including Google Font API, Webflow, Webpack.
What industry is Gate Bioscience in?+
Gate Bioscience operates in the Biotechnology industry.
Where is Gate Bioscience based?+
Gate Bioscience is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026